"CTTI’s unique model that involves all stakeholders in the clinical trial process as equal partners to identify solutions is one that should be replicated across the industry.”
Washington, DC (PRWEB) June 05, 2015
The Clinical Trials Transformation Initiative (CTTI) will be honored with a Regional Inspire Award for the Americas at DIA’s upcoming Annual Meeting. DIA’s Regional Inspire Awards program recognizes DIA’s outstanding volunteers for their leadership, level of excellence, and commitment to service.
CTTI will receive the Outstanding Contribution to Health Award that recognizes an organization that has made significant and innovative contributions to advancing health throughout the region.
“CTTI’s unique model that involves all stakeholders in the clinical trial process as equal partners to identify solutions is one that should be replicated across the industry,” said Susan Cantrell, senior vice president and managing director, DIA Americas. “The procedures and tools the organization has developed are streamlining and refining the process of conducting trials, ushering in a new gold standard in research development and leading to stronger evidence-based prevention and treatment options.”
CTTI, cofounded by Duke University and the U.S. Food and Drug Administration and hosted by Duke, develops recommendations, tools and resources to enable a high quality, efficient clinical trial system. The organization studies current clinical trials processes, identifies impediments to beneficial change, and develops consensus-driven, evidence-based recommendations and solutions to improve clinical trials.
DIA’s annual Inspire Awards nominees must have a record of outstanding commitment to raising the level of health and wellbeing worldwide. For more information about DIA’s Inspire Award program, click here.
Registration is open to attend the DIA 2015 51st Annual Meeting in Washington, D.C. June 14-18. Follow DIA’s Twitter feed (@DrugInfoAssn) and #DIA2015 for news about DIA 2015 51st Annual Meeting.
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.
DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan). For more information, visit our website at http://www.diaglobal.org or contact us via Twitter @DrugInfoAssn, LinkedIn or on Facebook.
ABOUT DIA’s 2015 ANNUAL MEETING
TheDIA 2015 51st Annual Meeting brings together a 7,000+ community of life sciences professionals at all levels and across all disciplines from around the globe that are involved in the discovery, development and life cycle management of medical products. Follow Annual Meeting news on Twitter using #DIA2015.